Literature DB >> 30355680

Plasticity of Amino Acid Residue 145 Near the Receptor Binding Site of H3 Swine Influenza A Viruses and Its Impact on Receptor Binding and Antibody Recognition.

Jefferson J S Santos1, Eugenio J Abente2, Adebimpe O Obadan1, Andrew J Thompson3, Lucas Ferreri1, Ginger Geiger1, Ana S Gonzalez-Reiche1,4, Nicola S Lewis5, David F Burke6, Daniela S Rajão1, James C Paulson3, Amy L Vincent2, Daniel R Perez7.   

Abstract

The hemagglutinin (HA), a glycoprotein on the surface of influenza A virus (IAV), initiates the virus life cycle by binding to terminal sialic acid (SA) residues on host cells. The HA gradually accumulates amino acid substitutions that allow IAV to escape immunity through a mechanism known as antigenic drift. We recently confirmed that a small set of amino acid residues are largely responsible for driving antigenic drift in swine-origin H3 IAV. All identified residues are located adjacent to the HA receptor binding site (RBS), suggesting that substitutions associated with antigenic drift may also influence receptor binding. Among those substitutions, residue 145 was shown to be a major determinant of antigenic evolution. To determine whether there are functional constraints to substitutions near the RBS and their impact on receptor binding and antigenic properties, we carried out site-directed mutagenesis experiments at the single-amino-acid level. We generated a panel of viruses carrying substitutions at residue 145 representing all 20 amino acids. Despite limited amino acid usage in nature, most substitutions at residue 145 were well tolerated without having a major impact on virus replication in vitro All substitution mutants retained receptor binding specificity, but the substitutions frequently led to decreased receptor binding. Glycan microarray analysis showed that substitutions at residue 145 modulate binding to a broad range of glycans. Furthermore, antigenic characterization identified specific substitutions at residue 145 that altered antibody recognition. This work provides a better understanding of the functional effects of amino acid substitutions near the RBS and the interplay between receptor binding and antigenic drift.IMPORTANCE The complex and continuous antigenic evolution of IAVs remains a major hurdle for vaccine selection and effective vaccination. On the hemagglutinin (HA) of the H3N2 IAVs, the amino acid substitution N 145 K causes significant antigenic changes. We show that amino acid 145 displays remarkable amino acid plasticity in vitro, tolerating multiple amino acid substitutions, many of which have not yet been observed in nature. Mutant viruses carrying substitutions at residue 145 showed no major impairment in virus replication in the presence of lower receptor binding avidity. However, their antigenic characterization confirmed the impact of the 145 K substitution in antibody immunodominance. We provide a better understanding of the functional effects of amino acid substitutions implicated in antigenic drift and its consequences for receptor binding and antigenicity. The mutation analyses presented in this report represent a significant data set to aid and test the ability of computational approaches to predict binding of glycans and in antigenic cartography analyses. This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Entities:  

Keywords:  H3 subtype; hemagglutinin; influenza vaccines; swine influenza; virus evolution

Mesh:

Substances:

Year:  2019        PMID: 30355680      PMCID: PMC6321904          DOI: 10.1128/JVI.01413-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.

Authors:  M N Matrosovich; A S Gambaryan; S Teneberg; V E Piskarev; S S Yamnikova; D K Lvov; J S Robertson; K A Karlsson
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

2.  Comparative protein structure modeling using Modeller.

Authors:  Ben Webb; Andrej Sali; Narayanan Eswar; Marc A Marti-Renom; M S Madhusudhan; David Eramian; Min-Yi Shen; Ursula Pieper
Journal:  Curr Protoc Bioinformatics       Date:  2006-10

3.  Plasmid-Based Reverse Genetics of Influenza A Virus.

Authors:  Daniel R Perez; Matthew Angel; Ana Silvia Gonzalez-Reiche; Jefferson Santos; Adebimpe Obadan; Luis Martinez-Sobrido
Journal:  Methods Mol Biol       Date:  2017

4.  Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells.

Authors:  E A Govorkova; M N Matrosovich; A B Tuzikov; N V Bovin; C Gerdil; B Fanget; R G Webster
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

5.  Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes.

Authors:  R Medeiros; N Escriou; N Naffakh; J C Manuguerra; S van der Werf
Journal:  Virology       Date:  2001-10-10       Impact factor: 3.616

6.  Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

Authors:  Björn F Koel; David F Burke; Theo M Bestebroer; Stefan van der Vliet; Gerben C M Zondag; Gaby Vervaet; Eugene Skepner; Nicola S Lewis; Monique I J Spronken; Colin A Russell; Mikhail Y Eropkin; Aeron C Hurt; Ian G Barr; Jan C de Jong; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

7.  Mapping the antigenic and genetic evolution of influenza virus.

Authors:  Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2004-06-24       Impact factor: 47.728

8.  WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.

Authors:  Alexander I Klimov; Rebecca Garten; Colin Russell; Ian G Barr; Terry G Besselaar; Rod Daniels; Othmar G Engelhardt; Gary Grohmann; Shigeyuki Itamura; Anne Kelso; John McCauley; Takato Odagiri; Derek Smith; Masato Tashiro; Xiyan Xu; Richard Webby; Dayan Wang; Zhiping Ye; Shu Yuelong; Wenqing Zhang; Nancy Cox
Journal:  Vaccine       Date:  2012-08-20       Impact factor: 3.641

9.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors.

Authors:  Shinya Yamada; Yasuo Suzuki; Takashi Suzuki; Mai Q Le; Chairul A Nidom; Yuko Sakai-Tagawa; Yukiko Muramoto; Mutsumi Ito; Maki Kiso; Taisuke Horimoto; Kyoko Shinya; Toshihiko Sawada; Makoto Kiso; Taiichi Usui; Takeomi Murata; Yipu Lin; Alan Hay; Lesley F Haire; David J Stevens; Rupert J Russell; Steven J Gamblin; John J Skehel; Yoshihiro Kawaoka
Journal:  Nature       Date:  2006-11-16       Impact factor: 49.962

10.  Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data.

Authors:  Matthew Kearse; Richard Moir; Amy Wilson; Steven Stones-Havas; Matthew Cheung; Shane Sturrock; Simon Buxton; Alex Cooper; Sidney Markowitz; Chris Duran; Tobias Thierer; Bruce Ashton; Peter Meintjes; Alexei Drummond
Journal:  Bioinformatics       Date:  2012-04-27       Impact factor: 6.937

View more
  5 in total

1.  Potential Antigenic Mismatch of the H3N2 Component of the 2019 Southern Hemisphere Influenza Vaccine.

Authors:  Sigrid Gouma; Madison Weirick; Scott E Hensley
Journal:  Clin Infect Dis       Date:  2020-05-23       Impact factor: 9.079

2.  Genetic and Antigenic Characterization of an Expanding H3 Influenza A Virus Clade in U.S. Swine Visualized by Nextstrain.

Authors:  Megan N Neveau; Michael A Zeller; Bryan S Kaplan; Carine K Souza; Phillip C Gauger; Amy L Vincent; Tavis K Anderson
Journal:  mSphere       Date:  2022-05-09       Impact factor: 5.029

3.  Recombinant hemagglutinin glycoproteins provide insight into binding to host cells by H5 influenza viruses in wild and domestic birds.

Authors:  Carmen Jerry; David Stallknecht; Christina Leyson; Roy Berghaus; Brian Jordan; Mary Pantin-Jackwood; Gavin Hitchener; Monique França
Journal:  Virology       Date:  2020-08-12       Impact factor: 3.616

4.  Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein.

Authors:  C Joaquín Cáceres; Stivalis Cardenas-Garcia; Aarti Jain; L Claire Gay; Silvia Carnaccini; Brittany Seibert; Lucas M Ferreri; Ginger Geiger; Algimantas Jasinskas; Rie Nakajima; Daniela S Rajao; Irina Isakova-Sivak; Larisa Rudenko; Amy L Vincent; D Huw Davies; Daniel R Perez
Journal:  Vaccines (Basel)       Date:  2021-06-27

5.  Antigenic and molecular characterization of low pathogenic avian influenza A(H9N2) viruses in sub-Saharan Africa from 2017 through 2019.

Authors:  Maxime Fusade-Boyer; Fidélia Djegui; Komla Batawui; Denis K Byuragaba; Jeremy C Jones; Fred Wabwire-Mangeni; Bernard Erima; Gladys Atim; Qouilazoni A Ukuli; Titus Tugume; Koffi Dogno; Komlan Adjabli; Mvibudulu Nzuzi; Rachidatou Adjin; Trushar Jeevan; Adam Rubrum; Wolali Go-Maro; Ghazi Kayali; Pamela McKenzie; Richard J Webby; Mariette F Ducatez
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.